Certainly! Here is a comprehensive, well-sourced answer to your question about patient groups, academic groups, and companies involved in Alzheimer's disease, with as much detail as possible and references for each statement.
1. Patient groups:
- Alzheimer's Association (USA): The leading voluntary health organization in Alzheimer's care, support, and research. Provides support groups, educational resources, advocacy, and funds research globally.
Source: alz.org/about/our-impact - Alzheimer's Disease International (ADI): The global umbrella organization of Alzheimer associations, representing over 100 nonprofit members worldwide. ADI coordinates advocacy, awareness, and support efforts globally.
Source: alzint.com/directory.html, alzint.org/our-members - Dementia Alliance International (DAI): A worldwide organization led by people with dementia, providing peer-to-peer support, advocacy, and education.
Source: dementiaallianceinternational.org - UsAgainstAlzheimer's: A US-based advocacy group focused on accelerating the discovery and development of a cure for Alzheimer's through policy, research, and awareness.
Source: usagainstalzheimers.org - Alzheimer's Impact Movement (AIM): Advocacy arm of the Alzheimer's Association, focused on advancing bipartisan legislation and research funding in the US.
Source: alzimpact.org - Leaders Engaged on Alzheimer's Disease (LEAD Coalition): A coalition of over 90 organizations in the US, including patient groups, research institutions, and industry, working collaboratively to stop Alzheimer's and related dementias.
Source: patientsrising.org/partners-coalitions - European Patients' Forum (EPF): An umbrella organization representing patient groups across Europe, including Alzheimer Europe, which advocates for dementia patients at the EU level.
Source: alzheimer-europe.org/our-work/partners/european-patients-forum - Latino Alzheimer's & Memory Disorders Alliance (LAMDA): A US-based nonprofit focused on supporting Latino caregivers and families affected by Alzheimer's and memory disorders.
Source: latinoalzheimersalliance.org/about-us - Dementia Society of America: Provides support, education, and advocacy for all forms of dementia, including Alzheimer's.
Source: dementiasociety.org - Alzheimer's South Africa (ASA): Provides support, counseling, and advocacy for people with dementia and their families in South Africa.
Source: adasa.org.za - Alzheimer Society of Canada: Offers support, education, and funds research for Alzheimer's and related dementias in Canada.
Source: alzheimer.ca/en - Alzheimer's New Zealand: Provides support, advocacy, and information for people with dementia and their families in New Zealand.
Source: alzheimers.org.nz - Dementia UK: Provides specialist dementia support for families through Admiral Nurses in the UK.
Source: dementiauk.org - Lewy Body Dementia Association (LBDA): Focuses on support and advocacy for people with Lewy body dementia, the second most common form of progressive dementia after Alzheimer's.
Source: aplaceformom.com/caregiver-resources/articles/big-list-of-alzheimers-resources - Regional/National Alzheimer Societies: There are Alzheimer societies in nearly every country, many of which are members of ADI.
Source: alzint.com/directory.html
2. Academic groups and institutions:
- National Institute on Aging (NIA) Alzheimer's Disease Research Centers (ADRCs): The NIA funds 35 ADRCs at major US academic institutions, which are at the forefront of Alzheimer's research, clinical trials, and care innovation.
Source: nia.nih.gov/health/clinical-trials-and-studies/find-alzheimers-disease-research-center - Mayo Clinic Alzheimer's Disease Research Center: Conducts research on brain aging, Alzheimer's, and related dementias, and provides support to patients and families.
Source: mayo.edu/research/centers-programs/alzheimers-disease-research-center/about/overview - Yale Alzheimer's Disease Research Center: NIH-funded center focused on research, clinical care, and education.
Source: medicine.yale.edu/adrc/ - Stanford Alzheimer's Disease Research Center: Part of a network of ADRCs, focused on translating research into improved diagnosis and care.
Source: med.stanford.edu/adrc.html - NYU Langone Alzheimer's Disease Research Center: Interdisciplinary research on brain aging and Alzheimer's, with a mission to expand research and clinical expertise.
Source: med.nyu.edu/centers-programs/alzheimers-disease-research/ - Alzheimer's Therapeutic Research Institute (ATRI), USC: Conducts large-scale clinical trials and co-leads the Alzheimer's Clinical Trials Consortium (ACTC).
Source: atri.usc.edu/groups/ - Indiana University School of Medicine: Leads comprehensive Alzheimer's research, including studies on early-onset forms.
Source: medicine.iu.edu/expertise/alzheimers - University of Texas Health Science Center at San Antonio: Major research center for Alzheimer's and dementia, especially in Hispanic populations.
Source: news.uthscsa.edu/new-research-provides-key-insight-into-alzheimers-disease-risk-across-populations/ - Brown University Center for Alzheimer's Disease Research: Focuses on clinical trials and translational research.
Source: alz.carney.brown.edu/ - Dementia Research Oxford (University of Oxford, UK): Brings together researchers and clinicians to translate molecular insights into treatment and prevention.
Source: neuroscience.ox.ac.uk/dementia-research-oxford - Ohio State Medical Center: Longstanding research in Alzheimer's disease and related dementias.
Source: wexnermedical.osu.edu/brain-spine-neuro/memory-disorders/alzheimers/research - Other global centers: Many countries have national Alzheimer research centers, often affiliated with universities or hospitals, and many are members of ADI.
Source: alzint.com/directory.html
3. Companies developing a drug:
- Biogen: Developed Aduhelm (aducanumab) and co-developed Leqembi (lecanemab) with Eisai; both are monoclonal antibodies targeting amyloid-beta.
Source: biogen.com, reuters.com/business/healthcare-pharmaceuticals/companies-alzheimers-race-after-us-nod-eisaibiogen-drug-2023-07-07/ - Eisai: Japanese pharma company, co-developer of Leqembi (lecanemab) with Biogen.
Source: reuters.com/business/healthcare-pharmaceuticals/companies-alzheimers-race-after-us-nod-eisaibiogen-drug-2023-07-07/ - Eli Lilly: Developer of donanemab, another monoclonal antibody targeting amyloid plaques, and other Alzheimer's drug candidates.
Source: finance.yahoo.com/news/blockbuster-alzheimers-drug-phase-3-eli-lilly-biogen-merck-axovant-beta-amyloid-185214938.html - Merck: Has several Alzheimer's drug candidates in its pipeline, including BACE inhibitors and other novel mechanisms.
Source: biopharmadive.com/news/cerevance-merck-alzheimers-drug-research-collaboration/629222/ - Alzheon: Developing ALZ-801, an oral amyloid-targeting drug in late-stage clinical trials.
Source: medicalstartups.org/top/alzheimers/ - Cassava Sciences: Developed simufilam, a small molecule drug targeting altered filamin A in Alzheimer's.
Source: lifesciencereport.com/stocks/companies-developing-alzheimer-s-drugs - Teva Pharmaceutical Industries: Pursuing Alzheimer's therapeutics through collaborations, including with MODAG GmbH.
Source: media.market.us/top-10-alzheimers-disease-therapeutics-companies/ - AC Immune: Swiss biotech developing vaccines and antibodies for Alzheimer's, partnered with Takeda and Genentech.
Source: ft.com/content/a7cb45a5-c2d7-4d7f-81f4-e4922d79b6c7 - Amylyx Pharmaceuticals: Developing AMX0035, a neuroprotective agent for neurodegenerative diseases including Alzheimer's.
Source: medicalstartups.org/top/alzheimers/ - Athira Pharma: Focused on small molecule therapies for neurodegeneration, including Alzheimer's.
Source: biotech-careers.org/business-area/alzheimers - Axon Neuroscience: Developing vaccines and immunotherapies targeting tau protein in Alzheimer's.
Source: biotech-careers.org/business-area/alzheimers - TauRx Pharmaceuticals: Developing hydromethylthionine mesylate (HMTM), a tau aggregation inhibitor.
Source: biospace.com/companies-to-watch-12-late-stage-contenders-in-neurodegenerative-disease - Cerevance: Biotech company with Alzheimer's drug candidates, partnered with Merck.
Source: biopharmadive.com/news/cerevance-merck-alzheimers-drug-research-collaboration/629222/ - Roche/Genentech: Developing anti-amyloid and anti-tau antibodies, including gantenerumab.
Source: pharmaceutical-technology.com/data-insights/innovators-peptide-based-compositions-for-alzheimers-disease-pharmaceutical/ - Other companies: There are dozens of additional biotech startups and pharmaceutical companies worldwide with Alzheimer's drug candidates in various stages of development.
Source: biotech-careers.org/business-area/alzheimers, medicalstartups.org/top/alzheimers/
4. Additional context:
- The Alzheimer's disease ecosystem is highly collaborative, with patient groups, academic centers, and industry often working together on research, clinical trials, and advocacy.
- Many patient advocacy groups are also involved in funding research and influencing policy.
- The drug development pipeline for Alzheimer's is large and diverse, with over 160 clinical trials and more than 120 drugs in development as of 2024, targeting amyloid, tau, neuroinflammation, synaptic health, and other mechanisms (PMID: 38659717).
- International collaborations, such as the Alzheimer's Disease Neuroimaging Initiative (ADNI), involve patient groups, academia, and industry partners (fnih.org/press-release/patient-advocacy-groups-industry-and-individuals-join-groundbreaking-public-private-partnership-to-continue-advancing-critical-alzheimers-disease-research).
5. References:
- Alzheimer's Association
- Alzheimer's Disease International Directory
- Dementia Alliance International
- UsAgainstAlzheimer's
- Alzheimer's Impact Movement
- LEAD Coalition
- European Patients' Forum
- Latino Alzheimer's & Memory Disorders Alliance
- Dementia Society of America
- Alzheimer's South Africa
- Alzheimer Society of Canada
- Alzheimer's New Zealand
- Dementia UK
- Lewy Body Dementia Association
- NIA ADRCs
- Mayo Clinic ADRC
- Yale ADRC
- Stanford ADRC
- NYU Langone ADRC
- ATRI
- Indiana University
- UT Health San Antonio
- Brown University
- Oxford Dementia Research
- Ohio State Medical Center
- Biogen
- Reuters: Biogen/Eisai
- Yahoo Finance: Eli Lilly
- BioPharma Dive: Merck
- Medical Startups: Alzheon, Amylyx
- Life Science Report: Cassava Sciences
- Market.us: Teva
- Financial Times: AC Immune
- BioTech Careers: Athira, Axon
- BioSpace: TauRx
- Pharmaceutical Technology: Roche/Genentech
- PubMed: Alzheimer's drug pipeline 2024
- FNIH: ADNI partnership
If you need more detail on any specific group, research center, or company, or want a breakdown by country or region, let me know!